However, the CARE FOR HOMe study with nondialysis CKD patients demonstrated that the quantity, composition, and function of HDL, including PON activity, do not independently predict cardiovascular outcomes after adjustment for traditional cardiovascular and renal risk factors (37). This evidence concerns the gene PON1 and chronic kidney disease.